-
How often do you include counseling on long-acting reversible contraceptives in your discussions of birth controls? Look for new opportunities, according to a recent presentation by Michael Policar, MD, MPH, medical director of the University of California San Francisco/Family PACT Program Support and Evaluation in Sacramento.
-
Your clinic has distributed brochures on contraceptive methods, put up posters in the waiting room and exam rooms, and passed out printed information along with pill packs.
-
Educate adolescents and young women about human papillomavirus (HPV) with new materials provided by the Association of Women's Health, Obstetric and Neonatal Nurses (AWHONN) "Be Confident!" campaign.
-
With partisan fighting increasingly the norm in Washington, one of the few potential points of agreement might be federal funding for so-called home visiting programs.
-
Shannon is a 15-year-old patient who is sexually active. She has previously used oral contraceptives, but Shannon experienced an unplanned pregnancy when she missed several days of pills in her pill pack and failed to come in for emergency contraception. What birth control methods can you offer?
-
Flip through your patient files from the last week. If you see heavy menstrual bleeding checked several times in your charts, there's a good reason: One-third of all women report such bleeding at some point during their lives.
-
Data continue to be generated related to the use of robotic surgery in gynecology. At the current time, what the future holds for this latest technology within our specialty is anyone's guess.
-
The authors analyzed data from the Women's Health Initiative (WHI) combined Estrogen/Progestin Trial to determine if new-onset breast tenderness (NOBT) was associated with the development of breast cancer.
-
In the last two months, there were four articles in the American Journal of Obstetrics & Gynecology and Obstetrics & Gynecology dealing with drugs that are commonly used in pregnancy and their possible contribution to adverse outcomes. One of these articles was particularly attention-getting.
-
In this issue: Two oral medications for relapsing-remitting MS in phase III development; antihypertensives find new uses; Ginkgo biloba does not prevent cognitive decline in elderly; and FDA Actions.